Deleted Tweet from Scott Gottlieb, M.D.

Specifically, #FDA will not be able to accept any regulatory submissions for FY 2019 for new drugs, medical devices, or biologics that require a fee payment and that are submitted during the lapse period, unless the required user fee was paid before December 22, 2018.